Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion type Assertion NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_head.
- NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_provenance.
- NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion evidence source_evidence_literature NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_provenance.
- NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion SIO_000772 12822676 NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_provenance.
- NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion wasDerivedFrom befree-20150227 NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_provenance.
- NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion wasGeneratedBy ECO_0000203 NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_provenance.